Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.

Schroder UK Public Private Trust, the investment vehicle operated by asset manager Schroder, has dumped its shareholding in Carrick Therapeutics, an Ireland-based biopharmaceutical spinout of University of Cambridge, according to the Irish Times. The trust sold its stake, valued at £18.2m ($23.4m) in September 2020, to venture capital firm Rosetta Capital as part of a…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.